Clik here to view.
メダクタインターナショナルがFrancesco Siccardiを次期最高経営責任者に任命
スイス・カステルサンピエトロ （ビジネスワイヤ） — 革新的な人工関節置換術／脊椎手術関連製品の設計で世界をリードする家族所有の非上場企業メダクタインターナショナルは本日、著名な生物医学工学者でメダクタインターナショナルの現エグゼクティブバイスプレジデントのFrancesco...
View ArticleClik here to view.
シアトル・ジェネティクスと武田薬品がCD30発現末梢性T細胞リンパ腫のフロントライン治療でアドセトリス（ブレンツキシマブ・ベドチン）を評価する第3相ECH...
米ワシントン州ボセル & マサチューセッツ州ケンブリッジ & 大阪 （ビジネスワイヤ） —...
View ArticleClik here to view.
Visioneering Technologies, Inc. Enters European Market
ATLANTA Visioneering Technologies, Inc. (ASX: VTI), an innovative US-based medical device company dedicated to developing advanced products that improve vision, today announced that Medilens Nordic...
View ArticleClik here to view.
Clik here to view.
GenAhead Bio and ERS Genomics Enter into CRISPR/Cas9 License Agreement
FUJISAWA CITY, Japan & DUBLIN GenAhead Bio Incorporated (“GenAhead”) and ERS Genomics Limited (“ERS Genomics”) announced today a non-exclusive license agreement to provide GenAhead with access...
View ArticleClik here to view.
GenAhead Bio：ERS GenomicsとCRISPR / Cas9技術基本特許における非独占的ライセンス契約を締結
藤沢市 (美國商業資訊)–GenAhead Bio Incorporated（以下「GenAhead」）とERS Genomics Limited（以下「ERS Genomics」）は、GenAheadにERS Genomicが管理するCRISPR /...
View ArticleClik here to view.
PharmAbcine宣布FDA受理TTAC-0001用于治疗复发胶质母细胞瘤的IND申请
韩国大田 (美国商业资讯) — PharmAbcine, Inc是一家临床阶段生物技术公司，开发新型抗体治疗药物，用于多种癌症适应证，该公司宣布已收到美国食品药品管理局(FDA)针对其旗舰抗体TTAC-0001在研新药(“IND”)申请而签发的“可开展研究通知书”。该通知书允许公司开始启动美国临床试验单位开展贝伐珠单抗(Avastin®)难治复发GBM患者II期临床试验。...
View ArticleClik here to view.
Seattle Genetics与武田发布ADCETRIS® (Brentuximab...
华盛顿州博瑟尔、马萨诸塞州剑桥和日本大阪 (美国商业资讯) — Seattle Genetics, Inc. (Nasdaq:SGEN)与武田药品工业株式会社(TSE:4502)今天宣布，3期ECHELON-2临床试验达到主要终点。该试验显示，ADCETRIS (brentuximab...
View ArticleClik here to view.
犹他大学Huntsman癌症研究所为犹他州首家质子治疗中心选用Mevion的紧凑型单室系统
马萨诸塞州利特尔顿 (美国商业资讯)–Mevion Medical System宣布，犹他大学(U of U) Huntsman癌症研究所(HCI)已签署合同，采购一台装备HYPERSCAN Pencil Beam ScanningTM (PBS)技术的MEVION S250i Proton Therapy System™。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
Celltrion and Teva Announce FDA Oncologic Drugs Advisory Committee Recommends...
SILVER SPRING, Md. & JERUSALEM Celltrion, Inc. (KRX:068270) and Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the U.S. Food and Drug Administration (FDA) Oncologic...
View ArticleClik here to view.
WellSky and Digi-Trax Partner to Power Safer and More Efficient Cellular...
LENEXA, Kan. WellSky, a leading health and community care technology company backed by TPG Capital, and Digi-Trax Corporation, a global leader in compliance labeling solutions, have formed an...
View ArticleClik here to view.
德累斯顿心脏中心成为Imricor的首家商业化临床单位
明尼阿波利斯 (美国商业资讯) — Imricor今天宣布，该公司与德国德累斯顿心脏中心签署Advantage-MR EP记录仪/刺激仪系统并支持Vision-MR器械1的首份商业化合同。该协议将德累斯顿心脏中心置于MRI引导心脏消融临床进展的前沿，使该医院成为成长中的介入心脏磁共振(iCMR)领域的全球领导者。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
PPG, Essilor Celebrate Launch of COLORFUL COMMUNITIES Project at Susrut Eye...
KOLKATA, India PPG (NYSE:PPG) and Essilor International today announced the launch of a COLORFUL COMMUNITIES™ project in Kolkata, India, that will help revitalize the Susrut Eye Foundation and...
View ArticleClik here to view.
HiFiBiO Therapeutics Acquires H-Immune Therapeutics
CAMBRIDGE, Mass. & PARIS & SHANGHAI HiFiBiO Therapeutics, a world leader in the discovery of therapeutic antibodies through single-cell screening and analysis, announced today the...
View ArticleClik here to view.
HEX在新加坡加密货币交易所BCoin.sg首次上线
香港 (美国商业资讯)–领先的医疗ICT公司HEX今天首次在新加坡领先的数字资产交易所BCoin.sg上线。 BCoin.sg交易所由常驻新加坡的首席执行官Davy...
View ArticleClik here to view.
Savonix and Tucker Medical Announce Partnership to Establish Digital...
SINGAPORE Savonix, a global leader in digital tests for cognitive health, and Tucker Medical, a multi-specialty practice offering personalized medicine and care in medical oncology,...
View ArticleClik here to view.
Biogen and Samsung Bioepis Announce European Launch of IMRALDI™(adalimumab),...
CAMBRIDGE, Mass. & INCHEON, Korea Biogen (Nasdaq:BIIB) and Samsung Bioepis Co., Ltd. today announced the European launch of IMRALDI™ (adalimumab), a biosimilar referencing HUMIRA®. Starting...
View ArticleClik here to view.
Foundation Medicine Announces Strategic Collaboration with Major...
CAMBRIDGE, Mass. Foundation Medicine, Inc. today announced a strategic collaboration with Novartis allowing the development of companion diagnostic (CDx) tests for the Novartis portfolio of targeted...
View ArticleClik here to view.
Takeda to Present Results from Phase 3 ALTA-1L Trial Highlighting...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that intracranial efficacy data from the Phase 3 ALTA-1L (ALK in Lung Cancer Trial of BrigAtinib...
View ArticleClik here to view.
武田呈报3期ALTA-1L试验结果，显示在晚期ALK+非小细胞肺癌一线治疗中，ALUNBRIG® (brigatinib)的颅内有效性优于克唑替尼
马萨诸塞州剑桥和日本大阪 (美国商业资讯) — 武田药品工业株式会社(Takeda Pharmaceutical Company Limited, TSE: 4502)今天宣布，3期ALTA-1L（ALK in Lung Cancer Trial of BrigAtinib in 1st...
View Article